AceView: Gene:BFAR, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView.

cDNA accession Links to the sequence	Tissue most 5' clones in red	Match mRNA	From bp to bp in mRNA	From bp to bp in accs.	Clone encodes complete protein (with AA variation)	Features	Anomalies detected by AceView	Accession match over (% length)	Base differences relative to genome (% identity)
NM_016561.2		.a	1 to 3042	1 to 3042	exact	RefSeq, AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	3042/3042 (100 %)	0 diff (100 %id)
CN482741	eye	.a	5 to 668	1 to 664		tiling clone,		664/665 (99 %)	1 diff (99.9 %id)
BQ067783	brain	.a	25 to 839	12 to 830				819/1087 (75 %)	14 diff (98.8 %id)
DN993308	brain, whole brain	.a	92 to 764	1 to 672				672/672 (100 %)	5 diff (99.3 %id)
BE619329	large cell carcinoma, lung	.a	100 to 797	1 to 695				695/953 (72 %)	12 diff (98.8 %id)
BX953765		.a	105 to 663	1 to 559				559/559 (100 %)	0 diff (100 %id)
DB464964	hippocampus	.a	113 to 545	1 to 430				430/439 (97 %)	7 diff (98.5 %id)
DB483143	hippocampus	.a	113 to 607	1 to 495				495/495 (100 %)	0 diff (100 %id)
TI_57219484		.a	120 to 891	31 to 805				775/805 (96 %)	9 diff (98.9 %id)
BX416231	neuroblastoma	.a	123 to 463	1 to 340				340/340 (100 %)	2 diff (99.5 %id)
BX381159	Placenta Cot 25-normalized	.a	123 to 745	1 to 638				638/638 (100 %)	22 diff (96.6 %id)
BI825002	pooled brain, lung, testis	.a	123 to 708	25 to 607				583/607 (96 %)	7 diff (98.9 %id)
TI_57197821		.a	123 to 708	25 to 607				583/607 (96 %)	7 diff (98.9 %id)
DB477866	hippocampus	.a	124 to 404	1 to 281				281/284 (98 %)	4 diff (98.6 %id)
CN363497	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.a	127 to 660	1 to 534				534/534 (100 %)	1 diff (99.9 %id)
BE314534	brain, neuroblastoma	.a	128 to 922	17 to 802				786/820 (95 %)	21 diff (97.5 %id)
AF173003		.a	129 to 2642	1 to 2514	exact	tiling clone, AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	2514/2514 (100 %)	13 diff (99.5 %id)
BG826870	muscle, rhabdomyosarcoma	.a	129 to 790	1 to 663				663/663 (100 %)	2 diff (99.7 %id)
BI114412	muscle, rhabdomyosarcoma	.a	129 to 921	1 to 788				788/826 (95 %)	20 diff (97.6 %id)
CX784114	human embryonic stem cells	.a	129 to 693	1 to 565				565/565 (100 %)	4 diff (99.3 %id)
BI753727	brain	.a	130 to 891	1 to 766				766/766 (100 %)	5 diff (99.4 %id)
TI_57217411		.a	130 to 891	69 to 838				770/1254 (61 %)	19 diff (98.5 %id)
DR157529	human embryonic stem cells differentiated toan early endodermal cell type	.a	131 to 916	1 to 786				786/786 (100 %)	1 diff (99.9 %id)
CD656233	Embryonic Stem cells	.a	131 to 851	12 to 729				718/813 (88 %)	17 diff (98.0 %id)
T35285	prostate gland	.a	131 to 498	1 to 368				368/368 (100 %)	4 diff (99.0 %id)
F05632	brain, total brain	.a	133 to 363	1 to 230				230/230 (100 %)	1 diff (99.6 %id)
Z44193	brain, total brain	.a	133 to 410	1 to 278				278/278 (100 %)	0 diff (100 %id)
BG760209	melanotic melanoma, high MDR (cell line), skin	.a	133 to 893	1 to 760				760/761 (99 %)	5 diff (99.4 %id)
BI754710	brain	.a	133 to 891	1 to 767				767/1183 (64 %)	13 diff (99.0 %id)
BM194259	leukopheresis	.a	134 to 531	1 to 398				398/398 (100 %)	11 diff (97.3 %id)
R12025	whole brain	.a	135 to 444	1 to 314				314/468 (67 %)	10 diff (97.9 %id)
BG248512	adenocarcinoma cell line, colon	.a	136 to 922	1 to 778				778/778 (100 %)	13 diff (98.4 %id)
BQ877878	dorsal root ganglia	.a	142 to 1005	1 to 873				873/901 (96 %)	12 diff (98.7 %id)
TI_57148343		.a	142 to 969	67 to 899				833/899 (92 %)	14 diff (98.5 %id)
CD628014		.a	143 to 784	29 to 665				637/665 (95 %)	15 diff (97.8 %id)
BI759664	pooled colon, kidney, stomach	.a	143 to 969	1 to 832				832/832 (100 %)	8 diff (99.1 %id)
BM450677	eye, retinoblastoma	.a	143 to 916	1 to 787				787/1020 (77 %)	16 diff (98.5 %id)
DB469614	hippocampus	.a	144 to 581	1 to 438				438/438 (100 %)	1 diff (99.8 %id)
CN363496	embryonic stem cells, cell lines H1, H7, andH9	.a	145 to 528	1 to 384				384/384 (100 %)	6 diff (98.5 %id)
BI715165	Pancreas, Purified pancreatic islet	.a	146 to 640	1 to 495				495/495 (100 %)	0 diff (100 %id)
T35906	blood, white blood cells	.a	146 to 422	1 to 278				278/278 (100 %)	1 diff (99.7 %id)
CX788585	human embryonic stem cells	.a	147 to 856	1 to 710				710/710 (100 %)	1 diff (99.9 %id)
DB465635	hippocampus	.a	148 to 566	1 to 419				419/419 (100 %)	2 diff (99.6 %id)
BE797036	lung, small cell carcinoma	.a	150 to 999	1 to 844				844/848 (99 %)	23 diff (97.3 %id)
BI912008	leukocyte	.a	150 to 890	22 to 766				745/767 (97 %)	17 diff (97.8 %id)
TI_57234798		.a	150 to 890	22 to 766				745/767 (97 %)	17 diff (97.8 %id)
BE787761	large cell carcinoma, lung	.a	152 to 908	1 to 749				749/863 (86 %)	21 diff (97.6 %id)
BG319590	skin	.a	154 to 513	1 to 360				360/360 (100 %)	0 diff (100 %id)
CN363499	embryonic stem cells, cell lines H1, H7, andH9	.a	155 to 815	1 to 662				662/662 (100 %)	3 diff (99.6 %id)
AL561344	B cells from Burkitt lymphoma	.a	155 to 1059	1 to 904				904/912 (99 %)	29 diff (96.9 %id)
AL540546	placenta	.a	156 to 1058	1 to 902				902/902 (100 %)	1 diff (99.9 %id)
AL550826	placenta, Placenta Cot 25-normalized	.a	156 to 1205	1 to 1044				1044/1050 (99 %)	10 diff (99.1 %id)
BX366953		.a	156 to 999	1 to 844				844/844 (100 %)	0 diff (100 %id)
AL558813	T cells from T cell leukemia	.a	156 to 1007	1 to 852				852/852 (100 %)	1 diff (99.9 %id)
BQ229180	melanotic melanoma, skin	.a	156 to 846	24 to 716				693/945 (73 %)	16 diff (98.4 %id)
AL552529	placenta, Placenta Cot 25-normalized	.a	157 to 1143	1 to 982				982/982 (100 %)	5 diff (99.5 %id)
AL553319	placenta, Placenta Cot 25-normalized	.a	157 to 1064	1 to 905				905/905 (100 %)	7 diff (99.3 %id)
CX756434	Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass	.a	157 to 887	1 to 731			Submitted on the opposite strand	731/731 (100 %)	3 diff (99.6 %id)
BX403870	neuroblastoma	.a	158 to 1231	1 to 1067				1067/1071 (99 %)	14 diff (98.7 %id)
BG824202	adenocarcinoma cell line, colon	.a	160 to 964	1 to 804				804/804 (100 %)	12 diff (98.6 %id)
CD653827	Embryonic Stem cells	.a	160 to 922	4 to 765				762/825 (92 %)	15 diff (98.2 %id)
BQ957728	large cell carcinoma, lung	.a	163 to 1065	1 to 904				904/935 (96 %)	2 diff (99.8 %id)
AL528521	brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized	.a	164 to 1064	34 to 933				900/933 (96 %)	11 diff (98.9 %id)
BQ876945	epidermoid carcinoma, cell line, lung	.a	166 to 751	1 to 586				586/1068 (54 %)	5 diff (99.6 %id)
BC003054	Lung, small cell carcinoma	.a	170 to 2666	1 to 2497	exact	tiling clone, available from MGC, AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	2497/2497 (100 %)	1 diff (100.0 %id)
AL516848	brain, neuroblastoma, neuroblastoma cells	.a	170 to 1064	1 to 894				894/894 (100 %)	3 diff (99.7 %id)
BE408506	choriocarcinoma, placenta	.a	170 to 895	1 to 718				718/753 (95 %)	13 diff (98.3 %id)
BG477636	melanotic melanoma, skin	.a	170 to 977	1 to 819				817/891 (91 %)	21 diff (97.7 %id)
BG476975	melanotic melanoma, skin	.a	170 to 806	1 to 637				637/637 (100 %)	6 diff (99.1 %id)
AA021128	eye, retina	.a	171 to 622	1 to 464				464/464 (100 %)	16 diff (96.6 %id)
BE407256	choriocarcinoma, placenta	.a	171 to 866	1 to 693				693/693 (100 %)	8 diff (98.9 %id)
BE302826	melanotic melanoma, skin	.a	172 to 765	1 to 594				594/594 (100 %)	3 diff (99.5 %id)
BG168745	hypernephroma, cell line, Kidney	.a	172 to 912	1 to 744				744/868 (85 %)	21 diff (97.6 %id)
BM478991	melanotic melanoma, skin	.a	172 to 851	1 to 680				680/1143 (59 %)	6 diff (99.5 %id)
CD652749	Embryonic Stem cells	.a	172 to 847	12 to 683				672/803 (83 %)	16 diff (98.1 %id)
BI771174	pooled lung and spleen	.a	173 to 755	1 to 627				555/777 (71 %)	50 diff (93.6 %id)
BI769595	pooled lung and spleen	.a	173 to 1117	1 to 943				943/945 (99 %)	20 diff (97.9 %id)
BQ424106	eye, retinoblastoma	.a	173 to 868	1 to 704				704/786 (89 %)	12 diff (98.5 %id)
TI_57179294		.a	173 to 755	30 to 656				555/806 (68 %)	54 diff (93.4 %id)
TI_57179374		.a	173 to 1117	100 to 1042				943/1044 (90 %)	26 diff (97.6 %id)
BI438495	Pancreas, Purified pancreatic islet	.a	174 to 764	1 to 591				591/591 (100 %)	1 diff (99.9 %id)
BM312046	Pancreas, Purified pancreatic islet	.a	175 to 699	1 to 525				525/525 (100 %)	0 diff (100 %id)
BU076524	Pancreas, Purified pancreatic islet	.a	175 to 816	1 to 642				642/642 (100 %)	1 diff (99.9 %id)
CD655109	Embryonic Stem cells	.a	175 to 963	12 to 796				785/807 (97 %)	19 diff (97.7 %id)
BE256065	eye, retinoblastoma	.a	176 to 741	1 to 568				568/568 (100 %)	6 diff (99.0 %id)
BE251536	eye, retinoblastoma	.a	176 to 882	1 to 701				701/703 (99 %)	12 diff (98.3 %id)
BG747056	adenocarcinoma cell line, colon	.a	179 to 1041	1 to 863				863/863 (100 %)	30 diff (96.6 %id)
BG324753	Kidney, renal cell adenocarcinoma	.a	180 to 774	1 to 594				594/594 (100 %)	1 diff (99.9 %id)
T09074		.a	181 to 479	1 to 301				301/301 (100 %)	2 diff (99.4 %id)
BG117496	adenocarcinoma, cell line, Liver	.a	181 to 869	1 to 686				686/945 (72 %)	14 diff (98.6 %id)
BM475315	eye, retinoblastoma	.a	182 to 1065	1 to 886				886/1057 (83 %)	10 diff (99.1 %id)
BM045403	carcinoma, cell line, Prostate	.a	184 to 921	1 to 750				750/899 (83 %)	31 diff (96.6 %id)
CD557395	testis	.a	184 to 979	31 to 839				807/918 (87 %)	25 diff (97.3 %id)
BE251889	eye, retinoblastoma	.a	185 to 545	1 to 361				361/401 (90 %)	6 diff (98.6 %id)
DA946844	Spleen	.a	186 to 753	2 to 568		capped		567/567 (100 %)	1 diff (99.9 %id)
BE266639	lung, small cell carcinoma	.a	189 to 823	1 to 634				634/757 (83 %)	11 diff (98.6 %id)
BE384830	melanotic melanoma, skin	.a	190 to 661	1 to 472				472/472 (100 %)	1 diff (99.8 %id)
AK291114		.a	193 to 1812	1 to 1620	exact			1620/1620 (100 %)	2 diff (99.9 %id)
AK313890		.a	193 to 1634	1 to 1442	L352S V354F			1442/1442 (100 %)	2 diff (99.9 %id)
BP242793	Liver	.a	193 to 756	1 to 564				564/580 (97 %)	17 diff (97.1 %id)
DA032777		.a	194 to 751	2 to 559		capped		558/562 (99 %)	3 diff (99.5 %id)
DA052756		.a	194 to 739	2 to 547		capped		546/546 (100 %)	0 diff (100 %id)
DA479332		.a	194 to 772	2 to 580		capped		579/579 (100 %)	1 diff (99.9 %id)
DA490231	brain	.a	194 to 703	2 to 511		capped		510/512 (99 %)	1 diff (99.9 %id)
BE874538	large cell carcinoma, undifferentiated, lung	.a	194 to 888	1 to 705				705/1125 (62 %)	26 diff (97.7 %id)
BE887732	leiomyosarcoma, uterus	.a	194 to 936	1 to 741				741/829 (89 %)	18 diff (97.9 %id)
DA652006		.a	194 to 760	2 to 568		capped		567/567 (100 %)	1 diff (99.9 %id)
DA733828		.a	194 to 810	2 to 619		capped		618/627 (98 %)	6 diff (99.1 %id)
DA736420		.a	194 to 1063	2 to 872		capped		871/884 (98 %)	6 diff (99.4 %id)
DA737399		.a	194 to 1019	2 to 834		capped		833/915 (91 %)	11 diff (98.8 %id)
DA825966	pericardium	.a	194 to 762	2 to 570		capped		569/569 (100 %)	0 diff (100 %id)
DA884890		.a	194 to 746	2 to 554		capped		553/553 (100 %)	0 diff (100 %id)
DA970090	stomach	.a	194 to 751	2 to 559		capped		558/562 (99 %)	2 diff (99.7 %id)
N30481	melanocyte	.a	203 to 638	1 to 436				436/438 (99 %)	2 diff (99.6 %id)
BG323716	Kidney, renal cell adenocarcinoma	.a	209 to 1062	1 to 853				853/855 (99 %)	15 diff (98.3 %id)
BG424301	Kidney, renal cell adenocarcinoma	.a	209 to 912	1 to 703				703/704 (99 %)	16 diff (97.8 %id)
BG114238	Bone, osteosarcoma, cell line	.a	237 to 919	1 to 686				686/686 (100 %)	6 diff (99.2 %id)
DA735744		.a	245 to 968	2 to 725		capped		724/724 (100 %)	0 diff (100 %id)
DA709511		.a	246 to 815	2 to 571		capped		570/570 (100 %)	0 diff (100 %id)
DA734103		.a	248 to 897	2 to 652		capped		651/655 (99 %)	5 diff (99.3 %id)
DA948092	Spleen	.a	258 to 818	2 to 562		capped		561/561 (100 %)	0 diff (100 %id)
DA653007		.a	263 to 814	2 to 553		capped		552/552 (100 %)	0 diff (100 %id)
TI_1948094198		.a	281 to 1052	134 to 913				780/1190 (65 %)	21 diff (98.3 %id)
TI_1948094638		.a	281 to 849	133 to 706				574/1255 (45 %)	21 diff (98.4 %id)
CV025910	mixed	.a	282 to 900	1 to 619				619/619 (100 %)	0 diff (100 %id)
BM556829	amelanotic melanoma, cell line, skin	.a	284 to 793	1 to 510				510/1082 (47 %)	9 diff (99.2 %id)
BP281915	bone marrow	.a	292 to 872	1 to 582				582/582 (100 %)	3 diff (99.5 %id)
BM830096	stomach	.a	292 to 889	1 to 598				598/598 (100 %)	0 diff (100 %id)
BG325434	Kidney, renal cell adenocarcinoma	.a	294 to 912	1 to 618				618/619 (99 %)	4 diff (99.4 %id)
BG325343	Kidney, renal cell adenocarcinoma	.a	294 to 1057	1 to 770				770/773 (99 %)	15 diff (98.1 %id)
BP329824	rectum	.a	302 to 888	1 to 588				588/588 (100 %)	7 diff (98.9 %id)
BE613878	leiomyosarcoma, uterus	.a	307 to 819	1 to 512			Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	512/512 (100 %)	2 diff (99.7 %id)
DA376968	thalamus	.a	334 to 885	2 to 553		capped		552/552 (100 %)	0 diff (100 %id)
BQ307001	breast	.a	349 to 903	1 to 552				552/552 (100 %)	14 diff (97.5 %id)
DA019291		.a	370 to 925	2 to 557		capped		556/556 (100 %)	1 diff (99.9 %id)
BP255826	Kidney	.a	377 to 958	1 to 582				582/582 (100 %)	1 diff (99.9 %id)
DA733270		.a	408 to 1065	2 to 662		capped		659/665 (99 %)	15 diff (97.8 %id)
BP268778	thyroid	.a	419 to 1001	1 to 584				584/584 (100 %)	2 diff (99.7 %id)
BE018503	cervix	.a	430 to 893	1 to 464				464/464 (100 %)	2 diff (99.6 %id)
BF795032	lymph, lymphoma, cell line	.a	435 to 1159	1 to 717				717/977 (73 %)	18 diff (98.2 %id)
CA488721		.a	468 to 1338	1 to 881				881/908 (97 %)	23 diff (97.5 %id)
BG281462	melanotic melanoma, skin	.a	491 to 1375	1 to 882				882/949 (92 %)	18 diff (98.2 %id)
BG281541	melanotic melanoma, skin	.a	492 to 1415	1 to 919				921/1034 (89 %)	29 diff (97.2 %id)
BE302562	melanotic melanoma, skin	.a	498 to 833	1 to 336				336/336 (100 %)	0 diff (100 %id)
BQ270753	insulinoma, Pancreas	.a	504 to 1044	8 to 548			Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	541/548 (98 %)	0 diff (100 %id)
BE277256	melanotic melanoma, skin	.a	511 to 1238	1 to 725				725/784 (92 %)	6 diff (99.3 %id)
BF025874	melanotic melanoma, skin	.a	511 to 1171	1 to 667				667/897 (74 %)	11 diff (98.8 %id)
BE274654	melanotic melanoma, skin	.a	512 to 1291	1 to 775				775/804 (96 %)	11 diff (98.7 %id)
CD628013		.a	557 to 1307	758 to 6				753/758 (99 %)	4 diff (99.5 %id)
BI859125	breast, mammary adenocarcinoma, cell line	.a	560 to 1292	1 to 734				734/734 (100 %)	1 diff (99.9 %id)
TI_57188084		.a	560 to 1292	49 to 782				734/734 (100 %)	1 diff (99.9 %id)
BP345970	synovial membrane	.a	560 to 1140	1 to 581				581/581 (100 %)	2 diff (99.7 %id)
CB146983	Liver	.a	564 to 1199	1 to 636				636/636 (100 %)	0 diff (100 %id)
DA730769		.a	596 to 1420	2 to 819		capped		818/821 (99 %)	13 diff (98.5 %id)
BX363831		.a	621 to 1619	1 to 990				990/996 (99 %)	18 diff (98.2 %id)
EC481159	Prostate	.a	622 to 726	1 to 105				105/105 (100 %)	1 diff (99.1 %id)
EC509765	Prostate	.a	622 to 726	1 to 99				99/99 (100 %)	6 diff (94.0 %id)
BP242916	Liver	.a	632 to 1218	1 to 587				587/587 (100 %)	4 diff (99.4 %id)
EC568138	Prostate	.a	634 to 726	17 to 105				89/105 (84 %)	6 diff (94.3 %id)
DA276068	corpus callosum	.a	643 to 1173	2 to 533		capped		532/532 (100 %)	1 diff (99.9 %id)
BF971239	adrenal cortex carcinoma, cell line, adrenal gland	.a	695 to 1447	1 to 753				753/942 (79 %)	9 diff (99.1 %id)
BU177506	melanotic melanoma, skin	.a	706 to 1532	35 to 873				839/879 (95 %)	39 diff (95.6 %id)
BE300516	melanotic melanoma, skin	.a	768 to 832	65 to 1				65/65 (100 %)	0 diff (100 %id)
BQ278227	mixed (pool of 40 RNAs)	.a	816 to 1551	1 to 746				746/902 (82 %)	14 diff (98.5 %id)
AA181590		.a	819 to 1120	5 to 305				301/305 (98 %)	7 diff (97.8 %id)
BU942681	mixed (pool of 40 RNAs)	.a	862 to 1646	1 to 794				794/797 (99 %)	12 diff (98.5 %id)
TI_1948094484		.a	907 to 1633	863 to 134			Submitted on the opposite strand	730/1223 (59 %)	11 diff (99.2 %id)
BX487642		.a	918 to 1477	47 to 605				559/605 (92 %)	6 diff (99.1 %id)
CB054940	brain, glioblastoma (pooled)	.a	918 to 1615	13 to 710				698/710 (98 %)	6 diff (99.2 %id)
TI_227716957		.a	920 to 1763	928 to 88		AAA	Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base)	841/1004 (83 %)	7 diff (99.4 %id)
TI_151733190		.a	959 to 1758	875 to 78		AAA	Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base)	798/972 (82 %)	6 diff (99.4 %id)
BQ188840	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.a	961 to 1269	1 to 309		fully sequenced,	Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base)	309/309 (100 %)	0 diff (100 %id)
BU659276	blood	.a	969 to 1487	14 to 532				519/532 (97 %)	6 diff (98.9 %id)
AW806578	stomach	.a	973 to 1517	546 to 3				544/546 (99 %)	1 diff (99.9 %id)
BE870602	adenocarcinoma, colon	.a	991 to 1753	1 to 755				755/1046 (72 %)	45 diff (95.7 %id)
R58120		.a	999 to 1273	1 to 274				274/274 (100 %)	7 diff (97.5 %id)
CR746500	melanotic melanoma, skin	.a	1002 to 1449	59 to 505				447/505 (88 %)	6 diff (98.9 %id)
BQ424556	melanotic melanoma, skin	.a	1002 to 1822	47 to 877				831/893 (93 %)	26 diff (97.1 %id)
DA505954	brain	.a	1058 to 1589	2 to 533		capped		532/532 (100 %)	1 diff (99.9 %id)
BX433429	adult brain, brain	.a	1063 to 1839	795 to 23				773/795 (97 %)	11 diff (98.7 %id)
Z45333	brain, total brain	.a	1072 to 1407	1 to 336				336/336 (100 %)	0 diff (100 %id)
F07972	brain, total brain	.a	1072 to 1389	1 to 318				318/318 (100 %)	0 diff (100 %id)
BF991251	placenta_normal	.a	1095 to 1548	468 to 16				453/468 (96 %)	1 diff (99.8 %id)
AL516847	brain, neuroblastoma, neuroblastoma cells	.a	1105 to 2124	1017 to 1				1017/1017 (100 %)	43 diff (95.8 %id)
BG122732	adenocarcinoma, cell line, Liver	.a	1117 to 1832	8 to 722		AAA		715/948 (75 %)	24 diff (97.5 %id)
BU191811	epithelioid carcinoma, Pancreas	.a	1133 to 2029	1 to 902				902/906 (99 %)	13 diff (98.6 %id)
BG388745	embryonal carcinoma, cell line, testis	.a	1149 to 1916	1 to 761				761/818 (93 %)	16 diff (98.1 %id)
AL568470	placenta	.a	1156 to 2121	970 to 1				970/970 (100 %)	32 diff (96.8 %id)
CD364317	Alveolar Macrophage, lung	.a	1171 to 1763	611 to 19		AAA	Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base)	593/593 (100 %)	0 diff (100 %id)
CK301197	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.a	1208 to 1758	569 to 19		fully sequenced, AAA	Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base)	551/551 (100 %)	0 diff (100 %id)
BP328811	rectum	.a	1242 to 1823	1 to 583				583/583 (100 %)	2 diff (99.7 %id)
BG031786	breast, mammary adenocarcinoma, cell line	.a	1243 to 1872	1 to 628				628/968 (64 %)	8 diff (99.2 %id)
AA096046		.a	1252 to 1474	56 to 277				222/280 (79 %)	8 diff (97.2 %id)
BQ440973	melanotic melanoma, skin	.a	1256 to 2105	12 to 864				853/870 (98 %)	16 diff (98.2 %id)
BM803085	duodenal adenocarcinoma, cell line, small intestine	.a	1258 to 1671	1 to 415				415/1413 (29 %)	11 diff (99.3 %id)
Z45856	brain, total brain	.a	1272 to 1621	1 to 350				350/350 (100 %)	0 diff (100 %id)
BX452578	adult brain, brain	.a	1309 to 1925	13 to 630				618/819 (75 %)	38 diff (95.4 %id)
BE160865	head_neck	.a	1350 to 1975	1 to 626				626/627 (99 %)	8 diff (98.8 %id)
BE160926	head_neck	.a	1352 to 1938	13 to 602				590/605 (97 %)	37 diff (93.9 %id)
BP255921	Kidney	.a	1372 to 1952	1 to 581				581/581 (100 %)	2 diff (99.7 %id)
CB215228	normal endometrium, late proliferativephase, cycle day 13, uterus	.a	1390 to 1932	1 to 543				543/543 (100 %)	0 diff (100 %id)
BF980855	duodenal adenocarcinoma, cell line, small intestine	.a	1424 to 2164	1 to 750				750/869 (86 %)	13 diff (98.6 %id)
AA171676		.a	1442 to 1720	1 to 278				278/278 (100 %)	3 diff (99.0 %id)
BI821349	pooled brain, lung, testis	.a	1463 to 2232	1 to 765				765/765 (100 %)	6 diff (99.3 %id)
TI_57200498		.a	1463 to 2232	37 to 801				765/801 (95 %)	6 diff (99.3 %id)
CF242861	Brain glioblastoma	.a	1529 to 2404	1 to 879				879/883 (99 %)	9 diff (99.0 %id)
AW390336	stomach	.a	1530 to 2039	513 to 1				513/516 (99 %)	14 diff (97.3 %id)
AA460071		.a	1541 to 2042	1 to 501				501/501 (100 %)	2 diff (99.7 %id)
CA439795	lung, Lung Focal Fibrosis	.a	1544 to 2134	8 to 598		AAA	Submitted on the opposite strand	591/598 (98 %)	6 diff (99.0 %id)
BG030783	breast, mammary adenocarcinoma, cell line	.a	1565 to 2429	1 to 864				864/870 (99 %)	42 diff (95.2 %id)
BP317535	pericardium	.a	1577 to 2151	1 to 575				575/581 (98 %)	7 diff (98.8 %id)
AA326030	brain, cerebellum	.a	1583 to 1915	1 to 341				341/370 (92 %)	11 diff (97.1 %id)
AW952375		.a	1584 to 2247	1 to 664				664/665 (99 %)	4 diff (99.4 %id)
R91016	liver and spleen	.a	1613 to 2022	1 to 412				412/419 (98 %)	6 diff (98.6 %id)
BE501405	Kidney	.a	1625 to 2149	526 to 2				525/526 (99 %)	0 diff (100 %id)
EC443669	Prostate	.a	1628 to 1722	95 to 1				95/95 (100 %)	0 diff (100 %id)
EC500692	Prostate	.a	1628 to 1726	100 to 1				100/100 (100 %)	4 diff (96.0 %id)
BU943913	adenocarcinoma, cell line, breast	.a	1634 to 2528	1 to 899				899/930 (96 %)	5 diff (99.5 %id)
AI888470	poorly differentiated adenocarcinoma withsignet ring cell features, stomach	.a	1647 to 2145	499 to 1				499/499 (100 %)	0 diff (100 %id)
AL564908	adult brain, brain	.a	1677 to 2646	968 to 1				968/1031 (93 %)	12 diff (98.9 %id)
BE858432	brain, glioblastoma (pooled)	.a	1678 to 2138	461 to 1				461/461 (100 %)	0 diff (100 %id)
AA303856	aorta	.a	1682 to 2084	1 to 405				405/405 (100 %)	4 diff (99.1 %id)
AL528491	brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized	.a	1685 to 2668	981 to 1				981/981 (100 %)	21 diff (97.9 %id)
BF793448	adrenal cortex carcinoma, cell line, adrenal gland	.a	1686 to 2092	1 to 412				412/412 (100 %)	3 diff (99.3 %id)
AI114830	Liver	.a	1694 to 2308	1 to 624				624/624 (100 %)	12 diff (98.1 %id)
DW435984	Liver	.a	1730 to 1967	17 to 254				238/254 (93 %)	6 diff (97.7 %id)
DW438061	Liver	.a	1730 to 1960	17 to 247				231/247 (93 %)	6 diff (97.6 %id)
DW466291	Liver	.a	1730 to 2066	17 to 353				337/353 (95 %)	6 diff (98.4 %id)
TI_149285400		.a	1746 to 2668	978 to 72				907/1198 (75 %)	0 diff (100 %id)
AL576345	placenta, Placenta Cot 25-normalized	.a	1751 to 2753	992 to 1				992/1016 (97 %)	16 diff (98.5 %id)
AA625438	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.a	1764 to 2328	1 to 565				565/565 (100 %)	1 diff (99.9 %id)
BQ086255	Islets of Langerhans, Pancreas	.a	1775 to 2227	1 to 453				453/457 (99 %)	1 diff (99.8 %id)
AA664410	lung	.a	1786 to 2137	353 to 2				352/353 (99 %)	0 diff (100 %id)
BM129678	Islets of Langerhans, Pancreas	.a	1791 to 2137	1 to 347				347/347 (100 %)	0 diff (100 %id)
BG032767	breast, mammary adenocarcinoma, cell line	.a	1812 to 2574	1 to 749				749/907 (82 %)	27 diff (97.1 %id)
BQ185738	eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid	.a	1814 to 2304	1 to 491				491/523 (93 %)	2 diff (99.7 %id)
BE160871	head_neck	.a	1833 to 2461	631 to 2			Submitted on the opposite strand	630/634 (99 %)	0 diff (100 %id)
TI_154062320		.a	1847 to 2642	849 to 61		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	789/931 (84 %)	14 diff (98.5 %id)
AW606819	head_neck	.a	1889 to 2479	596 to 12				585/596 (98 %)	0 diff (100 %id)
CF454305	peripheral nervous system	.a	1901 to 2740	34 to 864				831/927 (89 %)	13 diff (98.6 %id)
AA181642		.a	1921 to 2346	426 to 1				426/426 (100 %)	2 diff (99.6 %id)
BF980608	duodenal adenocarcinoma, cell line, small intestine	.a	1940 to 2573	12 to 643				632/981 (64 %)	6 diff (99.4 %id)
AL574694	placenta, Placenta Cot 25-normalized	.a	1949 to 3003	1040 to 1				1040/1102 (94 %)	20 diff (98.2 %id)
BQ574877	Chondrosarcoma Grade II, Left Pelvis	.a	1949 to 2642	711 to 19		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	693/693 (100 %)	3 diff (99.6 %id)
TI_57192044		.a	1957 to 2607	51 to 721		AAA		671/712 (94 %)	23 diff (96.8 %id)
BI862685	breast, mammary adenocarcinoma, cell line	.a	1959 to 2607	1 to 669		AAA		669/710 (94 %)	23 diff (96.8 %id)
AI969009	pooled germ cell tumors	.a	1966 to 2145	180 to 1				180/180 (100 %)	1 diff (99.5 %id)
AW264634	brain, three pooled meningiomas	.a	1968 to 2218	251 to 1				251/251 (100 %)	2 diff (99.3 %id)
BG751613	eye, normal pigmented retinal epithelium	.a	1978 to 2634	1 to 657				657/657 (100 %)	1 diff (99.9 %id)
BU154341	eye, retinoblastoma	.a	1982 to 2863	1 to 886				886/886 (100 %)	11 diff (98.8 %id)
BM990086	lung, Lung Focal Fibrosis	.a	1999 to 2642	662 to 19		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	644/644 (100 %)	0 diff (100 %id)
CA421112	Bone, Enchondroma cell line	.a	2006 to 2642	655 to 19		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	637/637 (100 %)	0 diff (100 %id)
BU680841	lung	.a	2007 to 2642	654 to 19		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	636/636 (100 %)	1 diff (99.9 %id)
AW238824	lung, cell line	.a	2009 to 2436	1 to 428				428/428 (100 %)	1 diff (99.8 %id)
CF127694	Chondrosarcoma Lung Metastasis cell lines, lung	.a	2025 to 2644	1 to 621				621/629 (98 %)	3 diff (99.6 %id)
TI_154193260		.a	2025 to 2813	51 to 840		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	790/790 (100 %)	7 diff (99.2 %id)
BI053952	placenta_normal	.a	2027 to 2462	468 to 37				432/468 (92 %)	0 diff (100 %id)
AA356807		.a	2038 to 2329	1 to 292				292/292 (100 %)	0 diff (100 %id)
ES315242	occipital scalp hair, skin	.a	2040 to 2220	1 to 180				180/180 (100 %)	1 diff (99.5 %id)
AL575914	placenta, Placenta Cot 25-normalized	.a	2042 to 3012	970 to 1				970/970 (100 %)	8 diff (99.2 %id)
DB366128		.a	2048 to 2642	594 to 1				594/596 (99 %)	13 diff (97.9 %id)
CB217364	mandible, pooled	.a	2051 to 2570	1 to 520		fully sequenced,	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	520/520 (100 %)	0 diff (100 %id)
BE879362	large cell carcinoma, undifferentiated, lung	.a	2061 to 2765	1 to 698				698/804 (86 %)	17 diff (97.9 %id)
BE966257	leiomyosarcoma, uterus	.a	2076 to 2700	636 to 15		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	622/923 (67 %)	0 diff (100 %id)
DB369992		.a	2076 to 2642	564 to 1				564/567 (99 %)	6 diff (99.0 %id)
BI054261	placenta_normal	.a	2077 to 2471	389 to 5				385/389 (98 %)	0 diff (100 %id)
DB362721		.a	2082 to 2642	559 to 1				559/560 (99 %)	5 diff (99.2 %id)
DB368075		.a	2092 to 2642	550 to 1				550/550 (100 %)	8 diff (98.6 %id)
BX366952		.a	2104 to 2999	889 to 1				889/889 (100 %)	5 diff (99.5 %id)
BU183907	melanotic melanoma, skin	.a	2106 to 2692	31 to 619				589/1046 (56 %)	20 diff (98.1 %id)
BI053953	placenta_normal	.a	2109 to 2424	342 to 30				313/342 (91 %)	0 diff (100 %id)
BX113524	liver and spleen	.a	2117 to 2813	1 to 697		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	697/697 (100 %)	1 diff (99.9 %id)
R01296	liver and spleen	.a	2117 to 2459	1 to 355		fully sequenced,		355/355 (100 %)	10 diff (97.2 %id)
DB365153		.a	2117 to 2642	526 to 1				526/579 (90 %)	18 diff (96.9 %id)
AL558812	T cells from T cell leukemia	.a	2135 to 3008	869 to 1				869/869 (100 %)	5 diff (99.5 %id)
R88757	liver and spleen	.a	2136 to 2643	520 to 3				518/521 (99 %)	0 diff (100 %id)
DB365816		.a	2137 to 2699	565 to 1				565/565 (100 %)	11 diff (98.1 %id)
AA071433		.a	2145 to 2620	1 to 488				488/492 (99 %)	13 diff (97.4 %id)
BG661288	Islets of Langerhans, Pancreas	.a	2147 to 2689	1 to 544				544/544 (100 %)	5 diff (99.1 %id)
AW007020	anaplastic oligodendroglioma, brain	.a	2148 to 2642	495 to 1				495/495 (100 %)	0 diff (100 %id)
CN363493	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.a	2149 to 2534	1 to 386				386/386 (100 %)	0 diff (100 %id)
BG287752	bladder, transitional cell papilloma, cell line	.a	2161 to 2811	1 to 648		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	648/650 (99 %)	20 diff (97.0 %id)
BP388115	pancreatic islet	.a	2178 to 2646	1 to 469			Submitted on the opposite strand	469/469 (100 %)	0 diff (100 %id)
FN147269	breast carcinoma	.a	2195 to 2303	110 to 1			Submitted on the opposite strand	110/110 (100 %)	1 diff (99.1 %id)
AA740894	germinal center B cell	.a	2195 to 2593	399 to 1				399/399 (100 %)	2 diff (99.5 %id)
AI087296	senescent fibroblast	.a	2203 to 2642	460 to 21		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	440/440 (100 %)	1 diff (99.8 %id)
AI762115	colon, colon tumor, RER+	.a	2205 to 2700	515 to 23		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	493/493 (100 %)	12 diff (97.6 %id)
AL582587	B cells from Burkitt lymphoma	.a	2214 to 2979	803 to 29				775/911 (85 %)	51 diff (94.5 %id)
AA639573	colon, colon tumor RER+	.a	2215 to 2813	614 to 19		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	596/596 (100 %)	5 diff (99.2 %id)
AW673743	cervix	.a	2224 to 2644	421 to 1				421/421 (100 %)	0 diff (100 %id)
BE302107	cervix	.a	2224 to 2645	422 to 1				422/422 (100 %)	0 diff (100 %id)
N28421	melanocyte	.a	2233 to 2648	1 to 417				417/419 (99 %)	2 diff (99.6 %id)
DB368894		.a	2234 to 2781	547 to 1				547/551 (99 %)	9 diff (98.4 %id)
AI963705	uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors	.a	2249 to 2642	414 to 21		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	394/394 (100 %)	1 diff (99.8 %id)
AW191063	adenocarcinoma, Pancreas	.a	2249 to 2642	428 to 34		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	395/395 (100 %)	13 diff (96.8 %id)
N35575	melanocyte	.a	2254 to 2496	1 to 245				245/252 (97 %)	3 diff (98.9 %id)
AW082616	colon, moderately differentiated adenocarcinoma	.a	2257 to 2643	389 to 1				389/389 (100 %)	2 diff (99.5 %id)
BG112925	Bone, osteosarcoma, cell line	.a	2260 to 2943	1 to 681				681/682 (99 %)	14 diff (98.0 %id)
AA706251	parathyroid gland, parathyroid tumor	.a	2264 to 2687	435 to 12		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	424/424 (100 %)	0 diff (100 %id)
CN363491	embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7	.a	2268 to 2955	1 to 689				689/689 (100 %)	6 diff (99.2 %id)
AA536062	colon	.a	2268 to 2657	1 to 390			Submitted on the opposite strand	390/486 (80 %)	13 diff (97.4 %id)
BI492494	cochlea, ear	.a	2281 to 2642	383 to 22		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	362/368 (98 %)	0 diff (100 %id)
AW021536. matches multiple genes	cochlea, ear	.a	2281 to 2642	7 to 368		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base), also hits gene RBBP6	362/368 (98 %)	0 diff (100 %id)
AA910229	Kidney	.a	2286 to 2642	357 to 1				357/357 (100 %)	1 diff (99.8 %id)
AA169634		.a	2292 to 2642	356 to 1				356/363 (98 %)	4 diff (98.9 %id)
BU621058	cell lines, Chondrosarcoma	.a	2292 to 3042	769 to 19		tiling clone, AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	751/751 (100 %)	0 diff (100 %id)
BQ270513	insulinoma, Pancreas	.a	2302 to 2813	529 to 18		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	512/512 (100 %)	0 diff (100 %id)
AW338398	adenocarcinoma, Pancreas	.a	2313 to 2700	400 to 13		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	388/388 (100 %)	2 diff (99.5 %id)
BF685821	leiomyosarcoma cell line, uterus	.a	2313 to 2396	724 to 804				761/970 (78 %)	38 diff (96.1 %id)
AI920903	adenocarcinoma, Pancreas	.a	2319 to 2813	515 to 19		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	497/497 (100 %)	11 diff (97.8 %id)
FN122911	breast carcinoma	.a	2327 to 2436	110 to 1			Submitted on the opposite strand	110/110 (100 %)	0 diff (100 %id)
BP386189	pancreatic islet	.a	2331 to 2621	1 to 291			Submitted on the opposite strand	291/294 (98 %)	1 diff (99.7 %id)
AW118427	poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus	.a	2355 to 2644	292 to 1				292/292 (100 %)	5 diff (98.3 %id)
DB552037	hippocampus	.a	2360 to 2813	1 to 455			Submitted on the opposite strand	455/455 (100 %)	3 diff (99.4 %id)
F04224	brain, total brain	.a	2375 to 2696	323 to 1				323/323 (100 %)	1 diff (99.7 %id)
AA627807	colon, colon tumor RER+	.a	2381 to 2703	325 to 6				320/325 (98 %)	0 diff (100 %id)
R01185	liver and spleen	.a	2429 to 2803	378 to 1		fully sequenced,		378/378 (100 %)	4 diff (99.0 %id)
F04223	brain, total brain	.a	2437 to 2696	261 to 1				261/261 (100 %)	1 diff (99.7 %id)
BE207440	melanotic melanoma, skin	.a	2501 to 2644	144 to 1				144/144 (100 %)	1 diff (99.4 %id)
AI949225	poorly differentiated adenocarcinoma withsignet ring cell features, stomach	.a	2528 to 3035	523 to 16		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	508/508 (100 %)	0 diff (100 %id)
AW835015	leiomios	.a	2534 to 2800	15 to 287				273/305 (89 %)	21 diff (93.2 %id)
DB531410	hippocampus	.a	2534 to 2813	1 to 281			Submitted on the opposite strand	281/281 (100 %)	3 diff (99.0 %id)
CB217363	mandible, pooled	.a	2540 to 3042	552 to 50		fully sequenced, AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	503/503 (100 %)	1 diff (99.9 %id)
AI859408	serous papillary carcinoma, high grade, 2pooled tumors, uterus	.a	2552 to 3042	490 to 1				490/490 (100 %)	1 diff (99.8 %id)
AA825497	germinal center B cell	.a	2555 to 3035	489 to 19		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	471/472 (99 %)	11 diff (97.7 %id)
AW173402	moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus	.a	2561 to 3039	476 to 1				476/476 (100 %)	1 diff (99.8 %id)
AA975595	2 pooled tumors (clear cell type), Kidney	.a	2573 to 3028	467 to 3				465/478 (97 %)	0 diff (100 %id)
AI091417	pooled	.a	2589 to 3043	459 to 4				456/459 (99 %)	0 diff (100 %id)
DB537221	hippocampus	.a	2604 to 3041	1 to 439			Submitted on the opposite strand	439/440 (99 %)	5 diff (98.9 %id)
DB546474	hippocampus	.a	2609 to 3034	1 to 426			Submitted on the opposite strand	426/427 (99 %)	1 diff (99.8 %id)
AI983724	brain, three pooled meningiomas	.a	2620 to 3035	416 to 1				416/474 (87 %)	2 diff (99.6 %id)
AI815044	adenocarcinoma, Pancreas	.a	2625 to 3039	415 to 1				415/415 (100 %)	0 diff (100 %id)
AI039943		.a	2641 to 3035	408 to 14		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	395/395 (100 %)	2 diff (99.5 %id)
AW078803	lung, cell line	.a	2641 to 2831	191 to 1				191/191 (100 %)	4 diff (98.0 %id)
AA973272	2 pooled tumors (clear cell type), Kidney	.a	2643 to 3043	406 to 6		tiling clone,		401/406 (98 %)	0 diff (100 %id)
AI887208	serous papillary carcinoma, high grade, 2pooled tumors, uterus	.a	2644 to 3027	411 to 28		AAA		384/391 (98 %)	0 diff (100 %id)
AI955440	uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors	.a	2645 to 3035	424 to 32		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	393/395 (99 %)	3 diff (99.3 %id)
AW085235	pooled	.a	2645 to 3043	401 to 3				399/401 (99 %)	0 diff (100 %id)
AW769328	colon, moderately-differentiated adenocarcinoma	.a	2649 to 3042	394 to 1				394/395 (99 %)	2 diff (99.5 %id)
BF512138		.a	2663 to 3042	397 to 18		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	380/390 (97 %)	1 diff (99.8 %id)
BF509045		.a	2663 to 3042	397 to 18		AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	380/390 (97 %)	1 diff (99.8 %id)
R37093	whole brain	.a	2712 to 3039	332 to 2				331/338 (97 %)	0 diff (100 %id)
Z41491	brain, total brain	.a	2729 to 3042	314 to 1				314/314 (100 %)	0 diff (100 %id)
AI701704	pooled	.a	2733 to 3037	305 to 1				305/305 (100 %)	0 diff (100 %id)
AI382320		.a	2741 to 3043	307 to 3				305/307 (99 %)	0 diff (100 %id)
DB532367	hippocampus	.a	2750 to 3035	1 to 285			Submitted on the opposite strand	285/285 (100 %)	19 diff (93.4 %id)
F04902	brain, total brain	.a	2760 to 3031	272 to 1				272/272 (100 %)	1 diff (99.7 %id)
F01893	brain, total brain	.a	2777 to 3031	255 to 1				255/255 (100 %)	2 diff (99.3 %id)
AI370501		.a	2786 to 3035	250 to 1				250/250 (100 %)	0 diff (100 %id)
D51659		.a	2794 to 3033	1 to 240				240/242 (99 %)	1 diff (99.6 %id)
D51766		.a	2794 to 3035	1 to 242				242/242 (100 %)	0 diff (100 %id)
D51963		.a	2794 to 3039	1 to 246				246/252 (97 %)	1 diff (99.7 %id)
D52004		.a	2794 to 3035	1 to 242				242/242 (100 %)	0 diff (100 %id)
BX385133		.a	2798 to 3039	1 to 242				242/242 (100 %)	0 diff (100 %id)
D51907		.a	2803 to 3039	1 to 238				238/239 (99 %)	8 diff (96.7 %id)
AA453912		.b	1 to 433	1 to 432		tiling clone,		432/432 (100 %)	1 diff (99.8 %id)
AA453405		.b	989 to 1381	397 to 5		tiling clone,		393/397 (98 %)	0 diff (100 %id)
TI_57238348		.c	1 to 830	33 to 864		tiling clone,		832/864 (96 %)	13 diff (98.5 %id)
BI912683	brain	.c	5 to 830	1 to 828		tiling clone,		828/828 (100 %)	7 diff (99.2 %id)
CN363492	embryonic stem cells, cell lines H1, H7, andH9	.c	704 to 1333	1 to 632		tiling clone,		632/632 (100 %)	4 diff (99.4 %id)
CR613606	adult brain	.d	1 to 1662	1 to 1662	exact	tiling clone,		1662/1662 (100 %)	0 diff (100 %id)
AL532885	adult brain, brain	.d	1 to 1055	1 to 1041				1041/1094 (95 %)	19 diff (98.3 %id)
BU507373	leiomyosarcoma, uterus	.d	10 to 834	1 to 830				830/842 (98 %)	6 diff (99.3 %id)
BF206705	brain, neuroblastoma	.d	52 to 780	1 to 717				721/899 (80 %)	27 diff (97.0 %id)
AA449625		.d	53 to 523	1 to 470				470/470 (100 %)	1 diff (99.8 %id)
AA233437	brain, neuroepithelial cells	.d	64 to 335	1 to 271				271/271 (100 %)	3 diff (98.9 %id)
AA449364		.d	845 to 1263	418 to 1				418/418 (100 %)	1 diff (99.8 %id)
AA252314	brain, neuroepithelial cells	.d	1887 to 2147	261 to 1		tiling clone,		261/261 (100 %)	0 diff (100 %id)
BP241341	Liver	.e	1 to 572	1 to 572		tiling clone,		572/572 (100 %)	4 diff (99.4 %id)
BP241443	Liver	.e	1 to 579	1 to 579		tiling clone,		579/579 (100 %)	2 diff (99.7 %id)
AK300778		.e	31 to 1478	1 to 1448	exact	tiling clone,		1448/1448 (100 %)	0 diff (100 %id)
DC386563		.e	31 to 554	1 to 524				524/524 (100 %)	0 diff (100 %id)
CN363498	embryonic stem cells, DMSO-treated H9 cellline	.f	1 to 790	1 to 791	M140R	tiling clone,		791/791 (100 %)	3 diff (99.7 %id)
CA411699	Chondrosarcoma Grade II, Left Pelvis	.f	255 to 845	611 to 21		tiling clone, AAA		591/591 (100 %)	5 diff (99.2 %id)
AA876364	2 pooled tumors (clear cell type), Kidney	.f	826 to 1238	416 to 4		tiling clone,		413/416 (99 %)	0 diff (100 %id)
AI191796		.f	898 to 1239	359 to 18		tiling clone,		342/359 (95 %)	0 diff (100 %id)
AI374649		.f	960 to 1239	291 to 12		AAA	Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base)	280/280 (100 %)	2 diff (99.3 %id)
CR608187	B cells (Ramos cell line) Cot 25-normalized	.g	1 to 1373	1 to 1373	exact	tiling clone,		1373/1373 (100 %)	0 diff (100 %id)
BX344707		.g	1 to 1159	1 to 1147	Q138X M140R			1147/1147 (100 %)	24 diff (98.0 %id)
BX385100		.g	1 to 1098	1 to 1093	M140R			1093/1093 (100 %)	15 diff (98.7 %id)
BG753051	eye, normal pigmented retinal epithelium	.g	12 to 839	1 to 825	D172E V179C A180G L206H S207L ...			825/826 (99 %)	14 diff (98.4 %id)
CR620062	fetal liver	.g	36 to 1396	1 to 1361	exact			1361/1361 (100 %)	0 diff (100 %id)
BX427255	fetal liver, Liver	.g	36 to 541	1 to 506		fully sequenced,		506/506 (100 %)	0 diff (100 %id)
BG475580	melanotic melanoma, skin	.g	39 to 942	1 to 897	E92A L94R F95Y P96F D97L ...			897/930 (96 %)	32 diff (96.6 %id)
BQ954274	leiomyosarcoma, uterus	.g	44 to 880	1 to 845	E186R V187S V188C L189P W190L ...			845/870 (97 %)	18 diff (98.0 %id)
BQ669897	epidermoid carcinoma, cell line, salivary gland	.g	46 to 951	1 to 916	Q138H Q139R M140G R167X W182*			916/940 (97 %)	41 diff (95.7 %id)
AA256647	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.g	50 to 134	1 to 84				84/84 (100 %)	1 diff (98.9 %id)
AW953467		.g	59 to 822	11 to 774	M140R N211K G212W R213K			764/774 (98 %)	9 diff (98.9 %id)
BM559420	amelanotic melanoma, cell line, skin	.g	163 to 984	1 to 822		AAA	Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base)	822/822 (100 %)	4 diff (99.6 %id)
BQ440179	melanotic melanoma, skin	.g	166 to 918	12 to 766				755/872 (86 %)	12 diff (98.7 %id)
BX344706		.g	213 to 1373	1153 to 1				1153/1153 (100 %)	60 diff (94.8 %id)
AI541176	Tissue culture	.g	249 to 984	732 to 1				732/742 (98 %)	29 diff (96.1 %id)
BX348905	Placenta Cot 25-normalized	.g	329 to 1169	1 to 849				849/941 (90 %)	36 diff (96.2 %id)
BX348904	Placenta Cot 25-normalized	.g	330 to 1033	1 to 708				708/937 (75 %)	55 diff (94.2 %id)
R00170	liver and spleen	.g	379 to 630	10 to 263				254/410 (61 %)	12 diff (97.1 %id)
BI439588	Pancreas, Purified pancreatic islet	.g	422 to 992	571 to 1				571/574 (99 %)	3 diff (99.5 %id)
TI_153957105		.g	463 to 1237	79 to 856		AAA		778/946 (82 %)	79 diff (91.7 %id)
BX427254	fetal liver, Liver	.g	511 to 1387	886 to 10		fully sequenced,		877/886 (98 %)	1 diff (99.9 %id)
BM311455	Pancreas, Purified pancreatic islet	.g	515 to 991	477 to 1				477/477 (100 %)	3 diff (99.4 %id)
AI753358	bone marrow stroma	.g	525 to 1003	479 to 1				479/479 (100 %)	3 diff (99.4 %id)
R67734	placenta	.g	536 to 993	1 to 462				462/462 (100 %)	18 diff (96.2 %id)
AW971230		.g	584 to 1014	533 to 103			Submitted on the opposite strand	431/549 (78 %)	1 diff (99.9 %id)
AA493570	thyroid	.g	584 to 999	416 to 1				416/421 (98 %)	1 diff (99.8 %id)
CA444021	Fibrosarcoma	.g	592 to 992	417 to 17		AAA	Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base)	401/401 (100 %)	0 diff (100 %id)
AI357750	uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors	.g	598 to 992	395 to 1				395/395 (100 %)	1 diff (99.8 %id)
TI_149295763		.g	634 to 1416	874 to 100		AAA	Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base)	775/925 (83 %)	16 diff (98.3 %id)
AA256664	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.g	656 to 986	331 to 1				331/331 (100 %)	0 diff (100 %id)
R00171	liver and spleen	.g	679 to 991	318 to 3				316/324 (97 %)	0 diff (100 %id)
BU184642	melanotic melanoma, cell line, skin	.g	713 to 1412	1 to 703		AAA	Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base)	703/703 (100 %)	11 diff (98.5 %id)
BF843969	head_neck	.g	743 to 871	130 to 2			Submitted on the opposite strand	129/136 (94 %)	0 diff (100 %id)
AA862554	pooled germ cell tumors	.g	746 to 992	247 to 1				247/247 (100 %)	0 diff (100 %id)
BG027749	Bone, osteosarcoma, cell line	.g	793 to 1412	1 to 616				616/635 (97 %)	15 diff (97.7 %id)
BU683872	lung, Primary Lung Cystic Fibrosis EpithelialCells	.g	800 to 1416	635 to 19		AAA	Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base)	617/617 (100 %)	0 diff (100 %id)
BI792371	Pancreas, Purified pancreatic islet	.g	859 to 1411	553 to 1				553/553 (100 %)	0 diff (100 %id)
AI718010	aorta	.g	914 to 1403	498 to 8				491/498 (98 %)	0 diff (100 %id)
AI016577		.g	915 to 1423	513 to 5		tiling clone,		509/513 (99 %)	0 diff (100 %id)
BQ008300	Chondrosarcoma, Left Pelvis	.g	918 to 1416	517 to 19		AAA	Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base)	499/499 (100 %)	3 diff (99.4 %id)
AA481439	ovarian tumor, ovary	.g	969 to 1412	461 to 17		AAA	Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base)	445/445 (100 %)	3 diff (99.4 %id)
AA507043	breast	.g	998 to 1416	419 to 1				419/428 (97 %)	0 diff (100 %id)
AI288835	2 pooled tumors (clear cell type), Kidney	.g	1012 to 1414	404 to 2				403/405 (99 %)	0 diff (100 %id)
AA515030	colon	.g	1021 to 1414	397 to 4				394/397 (99 %)	0 diff (100 %id)
AW302590	brain, three pooled meningiomas	.g	1032 to 1412	381 to 1				381/381 (100 %)	1 diff (99.8 %id)
BU566396	mixed (pool of 40 RNAs)	.g	1044 to 1412	1 to 369				369/373 (98 %)	2 diff (99.5 %id)
AI299930	2 pooled tumors (clear cell type), Kidney	.g	1045 to 1414	371 to 2				370/371 (99 %)	0 diff (100 %id)
AA863055	2 pooled tumors (clear cell type), Kidney	.g	1047 to 1414	368 to 2				367/368 (99 %)	0 diff (100 %id)
BI493749	cochlea, ear	.g	1056 to 1412	1 to 357		AAA	Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base)	357/357 (100 %)	4 diff (98.9 %id)
AI758382	Kidney	.g	1091 to 1414	330 to 7				324/330 (98 %)	0 diff (100 %id)
BF059341	pooled germ cell tumors	.g	1117 to 1412	296 to 1				296/296 (100 %)	2 diff (99.4 %id)
AW977663		.g	1121 to 1408	292 to 5			Submitted on the opposite strand	288/481 (59 %)	0 diff (100 %id)
AA810762	germinal center B cell	.g	1121 to 1412	315 to 24		AAA	Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base)	292/456 (64 %)	2 diff (99.6 %id)
AA812147	germinal center B cell	.g	1121 to 1412	314 to 24		AAA	Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base)	291/398 (73 %)	1 diff (99.8 %id)
R66124	placenta	.g	1123 to 1414	303 to 6				298/308 (96 %)	0 diff (100 %id)
AI375885	mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus	.g	1189 to 1411	223 to 1				223/431 (51 %)	0 diff (100 %id)
BI465053	testis	.h	1 to 723	1 to 723		tiling clone,		723/723 (100 %)	3 diff (99.6 %id)
DC396201	testis	.h	58 to 632	1 to 576				576/576 (100 %)	2 diff (99.7 %id)
BM462023	eye, retinoblastoma	.h	619 to 1599	1 to 985	L134Y F135S S136P W138G R139D ...	tiling clone,		985/1069 (92 %)	30 diff (97.2 %id)
CN363494	embryonic stem cells, DMSO-treated H9 cellline	.i	1 to 706	1 to 706		tiling clone,		706/706 (100 %)	0 diff (100 %id)
AI025786		.i	520 to 957	437 to 1		tiling clone,		437/437 (100 %)	2 diff (99.6 %id)
CO401500	Chondrosarcoma Lung Metastasis cell lines, lung	.j	-10 to 720	1 to 724	V134S L135S W136G L137W E138S ...	tiling clone,		724/815 (88 %)	13 diff (98.5 %id)
CR603825	neuroblastoma	.k	1 to 1177	1 to 1177	exact	tiling clone,		1177/1177 (100 %)	0 diff (100 %id)
AL515859	brain, neuroblastoma, neuroblastoma cells	.k	1 to 1084	1 to 1081	exact			1081/1127 (95 %)	14 diff (98.8 %id)
BX437923	neuroblastoma	.k	1 to 697	1 to 697	exact			697/697 (100 %)	0 diff (100 %id)
BM051099	eye, normal pigmented retinal epithelium	.k	61 to 794	1 to 733	T95I K135N Y138I L139*			733/737 (99 %)	7 diff (99.1 %id)
AL515858	brain, neuroblastoma, neuroblastoma cells	.k	106 to 1177	1066 to 1	E2L E3S P4K Q5A K6X ...			1066/1069 (99 %)	35 diff (96.8 %id)
CB140095	Liver	.k	248 to 632	1 to 385				385/385 (100 %)	1 diff (99.8 %id)
BE670620	carcinoid, lung	.l-u	1 to 424	432 to 8		tiling clone,		425/432 (98 %)	0 diff (100 %id)
BI030891	marrow	.l-u	370 to 640	271 to 1		tiling clone,		271/271 (100 %)	0 diff (100 %id)
DW424188	Liver	.l-u	424 to 671	17 to 264		tiling clone, AAA		248/264 (93 %)	6 diff (97.8 %id)
CN363495	embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells	.m	1 to 650	1 to 650	P2A L4V	tiling clone,		650/650 (100 %)	6 diff (99.1 %id)
BE670387	carcinoid, lung	.n	1 to 475	1 to 475		tiling clone,	Submitted on the opposite strand	475/475 (100 %)	2 diff (99.6 %id)
CR992350	T-Lymphocytes	.n	167 to 930	30 to 795	exact	tiling clone, AAA	Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base)	795/795 (100 %)	10 diff (98.8 %id)
M78938		.n	280 to 471	1 to 192				192/193 (99 %)	1 diff (99.5 %id)
AI890440	moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus	.o-u	1 to 411	490 to 80	F16X	tiling clone,		411/490 (83 %)	0 diff (100 %id)
AA321090	adipose tissue, brown	Gene BFAR, variant not shown
AA321091	adipose tissue, brown	Gene BFAR, variant not shown
AK297067	cord Blood	Gene BFAR, variant not shown					Suspected internal deletion, this clone was ignored
DB307936	hippocampus	Gene BFAR, variant not shown
DA298872	hippocampus	Gene BFAR, variant not shown				capped
AL524573	brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized	Gene BFAR, variant not shown					This clone was ignored
AL524574	brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized	Gene BFAR, variant not shown					This clone was ignored
DC297294		Gene BFAR, variant not shown					Suspected internal deletion, this clone was ignored
DB315241	brain	Gene BFAR, variant not shown					This clone was ignored
DA487739	brain	Gene BFAR, variant not shown				capped	This clone was ignored
AA741576	germinal center B cell	Gene BFAR, variant not shown				AAA	This clone was ignored
AA962493	2 pooled tumors (clear cell type), Kidney	Gene BFAR, variant not shown					Suspected internal deletion, this clone was ignored
AI359043	brain, glioblastoma (pooled)	Gene BFAR, variant not shown					This clone was ignored
AI421512	brain, glioblastoma (pooled)	Gene BFAR, variant not shown					This clone was ignored
AI825391	pooled germ cell tumors	Gene BFAR, variant not shown					This clone was ignored
BE466602	pooled germ cell tumors	Gene BFAR, variant not shown					This clone was ignored
BF939656	brain, glioblastoma (pooled)	Gene BFAR, variant not shown					This clone was ignored
BE536961	cervix	Gene BFAR, variant not shown					This clone was ignored
BF315886	brain, neuroblastoma	Gene BFAR, variant not shown					Suspected internal deletion, this clone was ignored
CD641080	pooled	Gene BFAR, variant not shown				AAA	This clone was ignored
DB368201		Gene BFAR, variant not shown					Suspected internal deletion, this clone was ignored
DA735845		Gene BFAR, variant not shown				capped	Suspected internal deletion, this clone was ignored
TI_151750788		Gene BFAR, variant not shown					Suspected internal deletion, this clone was ignored
TI_151793558		Gene BFAR, variant not shown					Suspected internal deletion, this clone was ignored